Human Health Division (HHD) Products

Product List by Brand Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Glifomet

Composition
Glifomet Tablet: Each film coated tablet contains Empagliflozin INN 5 mg and Metformin Hydrochloride BP 500 mg.

Indication
Glifomet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type
2 diabetes mellitus when treatment with both Empagliflozin and Metformin Hydrochloride is
inappropriate. Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2
diabetes mellitus and established cardiovascular disease

Dose & Administration
• The starting dose of Glifomet should be based on the patient's current regimen.
• Take twice daily with meals, with gradual dose escalation to reduce the gastrointestinal side effects due to Metformin Hydrochloride.
• The maximum recommended dose is 12.5 mg empagliflozin /1 000 mg metformin hydrochloride twice daily.
• Assess renal function before initiating Glifomet. Do not initiate or continue Glifomet if creatinine levels are greater than or equal to 1.5 mg /dL for males or 1.4 mg /dL for females or if eGFR is below 45 mL /min II.73 m2 or as directed by the physician.

Glix

Composition:
Glix™ 80 Tablet: Each Tablet contains Gliclazide BP 80 mg.
Glix™ 60 MR Tablet: Each modified release tablet contains Gliclazide BP 60 mg.

Indication:
Indicated for the treatment of Type-2 Diabetes.

Dose & Administration:
Glix™ 80 Tablet: Initially 40-80 mg daily, adjusted according to response, increased if necessary up to 160 mg once daily. Dose to be taken with breakfast, dosage higher than 160 mg to be given in divided doses; maximum 320 mg per day.

Glix™ MR Tablet: Initially 30 mg daily, dose to be taken with breakfast, adjustdose according to response every 4 weeks (after 2 weeks if no decrease in blood glucose); maximum 120 mg per day. Or as directed by the physician.